CL2012003582A1 - Forma de dosificacion farmaceutica que contiene un compuesto derivado de 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4', 9'-dihidro-3' h-espiro[ciclohexan-1,1'-pirano[3, 4, b]indol]-4-amina, un polimero y un tensioactivo; y su uso en el tratamiento del dolor agudo, visceral, neuropatico o cronico. - Google Patents

Forma de dosificacion farmaceutica que contiene un compuesto derivado de 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4', 9'-dihidro-3' h-espiro[ciclohexan-1,1'-pirano[3, 4, b]indol]-4-amina, un polimero y un tensioactivo; y su uso en el tratamiento del dolor agudo, visceral, neuropatico o cronico.

Info

Publication number
CL2012003582A1
CL2012003582A1 CL2012003582A CL2012003582A CL2012003582A1 CL 2012003582 A1 CL2012003582 A1 CL 2012003582A1 CL 2012003582 A CL2012003582 A CL 2012003582A CL 2012003582 A CL2012003582 A CL 2012003582A CL 2012003582 A1 CL2012003582 A1 CL 2012003582A1
Authority
CL
Chile
Prior art keywords
cyclohexan
visceral
neuropathic
pyran
spiro
Prior art date
Application number
CL2012003582A
Other languages
English (en)
Inventor
Nadja Gruning
Marc Schiller
Ingo Friedrich
Chris Kyrby
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43481034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012003582(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of CL2012003582A1 publication Critical patent/CL2012003582A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

Forma de dosificación farmacéutica que contiene un compuesto derivado de 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4', 9'-dihidro-3' h-espiro[ciclohexan-1,1'-pirano[3, 4, b]indol]-4-amina, un polímero y un tensioactivo; y su uso en el tratamiento del dolor agudo, visceral, neuropático o crónico.
CL2012003582A 2010-08-04 2012-12-19 Forma de dosificacion farmaceutica que contiene un compuesto derivado de 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4', 9'-dihidro-3' h-espiro[ciclohexan-1,1'-pirano[3, 4, b]indol]-4-amina, un polimero y un tensioactivo; y su uso en el tratamiento del dolor agudo, visceral, neuropatico o cronico. CL2012003582A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10008116 2010-08-04
US201161370643P 2011-08-04 2011-08-04

Publications (1)

Publication Number Publication Date
CL2012003582A1 true CL2012003582A1 (es) 2013-06-07

Family

ID=43481034

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003582A CL2012003582A1 (es) 2010-08-04 2012-12-19 Forma de dosificacion farmaceutica que contiene un compuesto derivado de 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4', 9'-dihidro-3' h-espiro[ciclohexan-1,1'-pirano[3, 4, b]indol]-4-amina, un polimero y un tensioactivo; y su uso en el tratamiento del dolor agudo, visceral, neuropatico o cronico.

Country Status (28)

Country Link
EP (1) EP2600839B1 (es)
JP (1) JP5792300B2 (es)
KR (1) KR101828768B1 (es)
CN (1) CN103179953A (es)
AR (1) AR082560A1 (es)
AU (1) AU2011287956B2 (es)
BR (1) BR112013002714A2 (es)
CA (1) CA2804878C (es)
CL (1) CL2012003582A1 (es)
CO (1) CO6640315A2 (es)
CY (1) CY1119887T1 (es)
DK (1) DK2600839T3 (es)
EC (1) ECSP13012419A (es)
ES (1) ES2665344T3 (es)
HR (1) HRP20180143T1 (es)
HU (1) HUE035543T2 (es)
IL (1) IL223880A (es)
LT (1) LT2600839T (es)
MX (1) MX345068B (es)
NZ (1) NZ604735A (es)
PE (1) PE20131107A1 (es)
PL (1) PL2600839T3 (es)
PT (1) PT2600839T (es)
RS (1) RS57027B1 (es)
RU (1) RU2582390C2 (es)
SI (1) SI2600839T1 (es)
WO (1) WO2012016699A2 (es)
ZA (1) ZA201300038B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6673924B2 (ja) 2015-01-23 2020-03-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 肝機能障害および／または腎機能障害を有する対象における疼痛を治療するためのセブラノパドール
WO2017148595A1 (en) 2016-02-29 2017-09-08 Grünenthal GmbH Titration of cebranopadol

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) * 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
DE102007009235A1 (de) * 2007-02-22 2008-09-18 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate

Also Published As

Publication number Publication date
EP2600839A2 (en) 2013-06-12
KR20130135238A (ko) 2013-12-10
ZA201300038B (en) 2013-09-25
SI2600839T1 (en) 2018-04-30
DK2600839T3 (da) 2018-01-29
ECSP13012419A (es) 2013-03-28
BR112013002714A2 (pt) 2017-05-30
CY1119887T1 (el) 2018-06-27
PL2600839T3 (pl) 2018-07-31
CA2804878C (en) 2019-01-08
NZ604735A (en) 2014-08-29
WO2012016699A8 (en) 2013-02-07
JP2013532698A (ja) 2013-08-19
WO2012016699A2 (en) 2012-02-09
AU2011287956A1 (en) 2013-01-10
RS57027B1 (sr) 2018-05-31
RU2013109134A (ru) 2014-09-10
JP5792300B2 (ja) 2015-10-07
HRP20180143T1 (hr) 2018-02-23
LT2600839T (lt) 2018-03-26
MX345068B (es) 2017-01-16
WO2012016699A3 (en) 2012-08-16
RU2582390C2 (ru) 2016-04-27
ES2665344T3 (es) 2018-04-25
CO6640315A2 (es) 2013-03-22
MX2013001114A (es) 2013-03-12
AU2011287956A8 (en) 2014-09-25
CA2804878A1 (en) 2012-02-09
PT2600839T (pt) 2018-04-17
KR101828768B1 (ko) 2018-02-13
PE20131107A1 (es) 2013-10-17
CN103179953A (zh) 2013-06-26
EP2600839B1 (en) 2018-01-10
AR082560A1 (es) 2012-12-19
HUE035543T2 (en) 2018-05-28
IL223880A (en) 2017-01-31
AU2011287956B2 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
CL2012003583A1 (es) Forma de dosificacion farmaceutica para administracion dos veces al dia, una vez al dia o con menos frecuencia, que contiene 6’-fluoro-(n-metil- o n,n-dimetil-)-4-fenil-4’,9’-dihidro-3’h-espiro[ciclohexan –1,1’-pirano[3,4,b]indol]-4-amina y un tensioactivo,
CL2013000218A1 (es) Forma de dosificacion farmaceutica para administracion oral de una vez al dia, que contiene 6’-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4’,9’-dihidro-3’h-espiro[ciclohexan-1,1’-pirano[3,4,b]indol]-4-amina, para uso en el tratamiento del dolor nocioceptivo.
CL2013000266A1 (es) Compuestos derivados de cis-tetrahidroespiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4-amina; combinacion y formulacion farmaceutica; y uso en el tratamiento del dolor neuropatico y/o cronico.
CL2007002167A1 (es) Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer.
TN2011000239A1 (en) Hsp90 inhibitor combinations
CL2013003577A1 (es) Uso de una composicion farmaceutica que comprende panobinostat y ruxolitinib en la prevencion y/o tratamiento de neoplasias mieloproliferativas.
EP3039019A4 (en) Azaspiro[4.5]decane derivatives and use thereof
PL2600838T3 (pl) Farmaceutyczna postać dawkowania zawierająca 6'-fluoro-(N-metylo- lub N,N-dimetylo)-4-fenylo-4'9'-dihydro-3'H-spiro[cykloheksano-1,1'-pirano[3,4b]indolo]-4-aminę
EA201270264A1 (ru) Лечение метастазов в головной мозг ингибиторами рецепторов эндотелина в комбинации с цитотоксическим химиотерапевтическим средством
CL2015001202A1 (es) Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer.
EP3263125A3 (en) Antagonism of the vip signaling pathway
CL2014000606A1 (es) Combinacion farmaceutica que comprende al compuesto 2-{2-[(2s)-2-metil-2,3-dihidro-1h-indol-1-il]-2-oxoetil}-6-(morfolin-4-il)pirimidin-4-(3h)-ona y al menos un inhibidor de la via de mapk; composicion farmaceutica; kit farmaceutico; su uso en el tratamiento del cancer.
CL2012003582A1 (es) Forma de dosificacion farmaceutica que contiene un compuesto derivado de 6'-fluoro-(n-metil- o n,n-dimetil)-4-fenil-4', 9'-dihidro-3' h-espiro[ciclohexan-1,1'-pirano[3, 4, b]indol]-4-amina, un polimero y un tensioactivo; y su uso en el tratamiento del dolor agudo, visceral, neuropatico o cronico.
CL2008001322A1 (es) Compuestos derivados de triazolil-aminopirimidina, sustituida con heterociclos; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2009000264A1 (es) Uso de una combinacion farmaceutica que comprende una sal de bis-tiazolio o uno de sus precursores y artemisina o uno de sus derivados, para el tratamiento y/o prevencion de la malaria severa; uso de la composicion farmaceutica y del kit farmaceutico que la comprenden.
CL2012000632A1 (es) Compuestos derivados de indol, activadores de nurr-1; y su uso para el tratamiento y/o la prevención de una enfermedad neurodegenerativa tal como la enfermedad de parkinson.
CL2012000355A1 (es) Compuestos derivados de 4-amino-butenamida; composicion farmaceutica; y uso en el tratamiento de la epoc.
HRP20171438T1 (hr) Farmaceutski pripravak koji sadrži (1r,4r)-6'-fluoro-n,n-dimetil-4-fenil-4',9'-dihidro-3'h-spiro[cikloheksan-1,1'-pirano'[3,4,b]indol]-4-amin i paracetamol ili propacetamol
EA201400857A1 (ru) (1R,4R)-6'-ФТОР-(N-МЕТИЛ- ИЛИ N,N-ДИМЕТИЛ)-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН ДЛЯ ЛЕЧЕНИЯ ФИБРОМИАЛГИИ И СИНДРОМА ХРОНИЧЕСКОЙ УСТАЛОСТИ
CA138925S (en) Lavatory dispensing device
CY1117385T1 (el) Φαρμακευτικη μορφη δοσολογιας περιλαμβανουσα 6'-φθορο-(ν-μεθυλ-ή ν,ν-διμεθυλ-)-4-φαινυλ-4΄,9'-διϋδρο-3ή-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4,β]ινδολ]-4-αμινη
UA97716U (uk) Лікарський засіб у формі сиропу, що містить фенспіриду гідрохлорид
CL2010001615A1 (es) Uso de eufol en el tratamiento de la inflamacion y el dolor neuropatico.
CL2008001216A1 (es) Compuestos derivados de pirazol-3-il-amino-pirimidina; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2010001424A1 (es) Compuestos derivados de azacarbolinas; compuestos intermediarios; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento del cancer.